Rani Therapeutics (RANI)
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and dr...
- Open
- 0.8036
- High
- 0.8036
- Low
- 0.7641
- Prev. Close
- 0.7920
- Volume
- 322.97K
- Turnover
- 251.41K
- Avg Price
- 0.7784
- Bid/Ask Ratio
- --
- Amplitude
- 4.99%
- 52wk High
- 3.8700
- Volume Ratio
- 0.13
- Turnover Ratio
- 0.50%
Rani Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 29, 2026Price forecast
$7.50865.38%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 8 hours ago
Rani Therapeutics to present at Canaccord Genuity Annual Growth Conference
- PUBT · Aug 4 at 07:49 PM
Rani Therapeutics files Form 3 for director Michelle Gilson
- PUBT · Aug 4 at 07:01 AM
Rani Therapeutics names Michelle Gilson to board as audit committee chair
- Tip Ranks · Jul 23 at 09:03 PM
Top Insider Makes Bold Move on Rani Therapeutics Stock
- PUBT · Jul 23 at 03:11 PM
Rani Therapeutics director, 10% owner Mir A. Imran buys 36,000 shares worth $24,840
- benzinga_article · Jul 22 at 12:05 PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
